Calcitonin gene polymorphismCALCA-624 (T/C) and ovarian cancer
2005; Wiley; Volume: 46; Issue: 1 Linguagem: Inglês
10.1002/em.20134
ISSN1098-2280
AutoresMarc T. Goodman, Robert E. Ferrell, Katharine McDuffie, Pamela J. Thompson, Lynne R. Wilkens, Abigail W. Bushley, Ko-Hui Tung, Michael E. Carney, Roberta B. Ness,
Tópico(s)Hormonal Regulation and Hypertension
ResumoEnvironmental and Molecular MutagenesisVolume 46, Issue 1 p. 53-58 Research Article Calcitonin gene polymorphism CALCA-624 (T/C) and ovarian cancer† Marc T. Goodman, Corresponding Author Marc T. Goodman [email protected] Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiEtiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813. Phone (808) 586-2987; Fax: (808) 586-2982Search for more papers by this authorRobert Ferrell, Robert Ferrell University of Pittsburgh Graduate School of Public Health, Pittsburgh, PennsylvaniaSearch for more papers by this authorKatharine McDuffie, Katharine McDuffie Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorPamela J. Thompson, Pamela J. Thompson Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorLynne R. Wilkens, Lynne R. Wilkens Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorAbigail W. Bushley, Abigail W. Bushley Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorKo-Hui Tung, Ko-Hui Tung Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorMichael E. Carney, Michael E. Carney Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorRoberta B. Ness, Roberta B. Ness University of Pittsburgh Graduate School of Public Health, Pittsburgh, PennsylvaniaSearch for more papers by this author Marc T. Goodman, Corresponding Author Marc T. Goodman [email protected] Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiEtiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813. Phone (808) 586-2987; Fax: (808) 586-2982Search for more papers by this authorRobert Ferrell, Robert Ferrell University of Pittsburgh Graduate School of Public Health, Pittsburgh, PennsylvaniaSearch for more papers by this authorKatharine McDuffie, Katharine McDuffie Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorPamela J. Thompson, Pamela J. Thompson Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorLynne R. Wilkens, Lynne R. Wilkens Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorAbigail W. Bushley, Abigail W. Bushley Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorKo-Hui Tung, Ko-Hui Tung Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorMichael E. Carney, Michael E. Carney Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HawaiiSearch for more papers by this authorRoberta B. Ness, Roberta B. Ness University of Pittsburgh Graduate School of Public Health, Pittsburgh, PennsylvaniaSearch for more papers by this author First published: 02 May 2005 https://doi.org/10.1002/em.20134Citations: 14 † The contents of this paper are solely the responsibility of the authors and does not necessarily represent the official views or policies of the National Cancer Institute AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Abstract In a previous analysis, we reported an inverse association of dietary calcium intake with the risk of ovarian cancer (Goodman et al. 2002. Am J Epidemiol 156:148–57). The CALCA gene codes for calcitonin, an important regulator of bone calcium metabolism. Data from a population-based case-control study conducted in Hawaii were used to examine the hypothesis that a T → C transition 624 base pairs upstream (−624) of the translation initiation codon of the CALCA gene influences the risk of ovarian malignancy. A structured interview was conducted for 182 histologically confirmed ovarian cancer cases and 219 controls. Blood specimens were collected from the subjects' at their homes. A significant negative trend (P for trend: 0.02) in the odds ratios (ORs) was found with increasing intake of calcium. Women with any CALCA C allele were at nonsignificantly higher risk of ovarian cancer (OR: 1.5, 95% CI: 0.9–2.3) compared to women with the TT genotype and the risk increased with the number of C alleles (P for trend: 0.05). When further analyzed within ethnic subgroups, a significant positive association was found among Japanese for CALCA CT (OR: 2.3, 95% CI: 1.0–5.3) and CALCA CC (OR: 7.2, 95% CI: 1.1–46.0) compared with Japanese women who were homozygous for the T allele. The trend in risk associated with the C allele was most significant among women who had used oral contraceptives (P for trend: 0.05), had been pregnant (P for trend: 0.04), and had nonmucinous histological types of ovarian cancer (P for trend: 0.02). However, the association of ovarian cancer risk with the CALCA genotype was not significantly modified by any of the dietary, nondietary, or clinical variables included in this study. These preliminary data suggest a strong positive association of the CALCA C allele with the risk of ovarian cancer among some subgroups. Environ. Mol. Mutagen., 2005. © 2005 Wiley-Liss, Inc. REFERENCES Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, Conti E, La Vecchia C. 2001. Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 93: 911– 915. Buervenich S, Xiang F, Sydow O, Jonsson EG, Sedvall GC, Anvret M, Olson L. 2001. Identification of four novel polymorphisms in the calcitonin/α-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression. Hum Mut 416: 1– 9. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. 1979. 'Incessant ovulation' and ovarian cancer. Lancet 2: 170– 173. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon T, Wilkens LR, Guo C, Le Marchand L. 2001. Multiethnic case-control study of ovarian cancer and polymorphisms in genes involved in catechol estrogen formation and metabolism. Cancer Epidemiol Biomark Prev 10: 209– 216. Goodman MT, Wu AH, Tung K-H, McDuffie K, Kolonel LN, Nomura AMY, Terada K, Wilkens LR, Murphy S, Hankin JH. 2002. The association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 156: 148– 157. Hobson SA, McNeil SE, Lee F, Rodland KD. 2000. Signal transduction mechanisms linking increased extracellular calcium to proliferation in ovarian surface epithelial cells. Exp Cell Res 258: 1– 11. Hosmer D, Lemeshow S. 1989. Applied logistic regression. New York: John Wiley and Sons. Kitazawa R, Kitazawa S, Matui M, Maeda S. 1997. In situ detection of parathyroid hormone related protein in ovarian clear cell carcinoma. Hum Pathol 27: 379– 382. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, Nagamine FS. 2000. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151: 346– 357. Linkhart TA, Mohan S. 1989. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125: 1484– 1491. Lipkin M, Newmark HL. 1999. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr 18( Suppl): 392– 397. Livak KJ. 2003. SNP genotyping by the 5′-nuclease reaction. Methods Mol Biol 212: 129– 147. Martinez ME, Willett WC. 1998. Calcium, vitamin D, colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomark Prev 7: 163– 198. Matias-Guiu X, Prat J, Young RH, Capen CC, Rosol TJ, Delellis RA, Scully RE. 1994. Human parathyroid hormone-related protein in ovarian small cell carcinoma. Cancer 73: 1878– 1881. McCarty MF. 2000. Parathyroid hormone may be a cancer promoter—an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypoth 54: 475– 482. Mori H, Harabuchi I, Miyake H, Casagrande JT, Henderson BE, Ross RK. 1988. Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol 128: 771– 777. Pfeilschifter J, Laukhuf F, Muller-Beckmann B, Blum WF, Pfister T, Ziegler R. 1995. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96: 767– 774. Scully RE, Sobin LH. 1999. Histological typing of ovarian tumours. Berlin, New York: Springer. EM Shambaugh, MA Weiss, editors. 1977. SEER summary staging guide. Bethesda: National Cancer Institute. USDA Nutrient Data Base for Nationwide Food Surveys. 1991. Release No. 7. Riverdale, MD: Nutrient Data Laboratory, Agricultural Research Service. USDA Nutrient Data Base for Standard Reference. 1993. Release No. 10. Riverdale, MD: Nutrient Data Laboratory, Agricultural Research Service. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP. 1996. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Br J Cancer 74: 1242– 1247. Citing Literature Volume46, Issue1July 2005Pages 53-58 ReferencesRelatedInformation
Referência(s)